Drug sensitivity of single cancer cells is predicted by changes in mass accumulation rate

Drug sensitivity of single cancer cells is predicted by changes in mass accumulation rate

Assays that can determine the response of tumor cells to cancer therapeutics could greatly aid the selection of drug regimens for individual patients. However, the utility of current functional assays is limited, and predictive genetic biomarkers are available for only a small fraction of cancer the...

Full description

Bibliographic Details
Main Authors: Maire, Cecile L (Author), Murakami, Mark A (Author), Knoff, David S (Author), Liu, Huiyun (Author), Idbaih, Ahmed (Author), Weinstock, David M (Author), Ligon, Keith L (Author), Stevens, Mark M. (Contributor), Chou, Shijie Nigel (Contributor), Kikuchi, Yuki (Contributor), Kimmerling, Robert John (Contributor), Calistri, Nicholas L (Contributor), Cermak, Nathan (Contributor), Olcum, Selim A. (Contributor), Cordero, Nicolas (Contributor), Manalis, Scott R (Contributor), Haidar, Samer, S.M. Massachusetts Institute of Technology (Author), Wen, P. (Author)
Other Authors: Massachusetts Institute of Technology. Department of Biological Engineering (Contributor), Massachusetts Institute of Technology. Department of Biology (Contributor), Massachusetts Institute of Technology. Microsystems Technology Laboratories (Contributor), Koch Institute for Integrative Cancer Research at MIT (Contributor), Manalis, Scott (Contributor), Wen, Patrick (Contributor)
Format: Article
Language:English
Published: Nature Publishing Group, 2017-05-04T16:33:36Z.
Subjects:
Article
Online Access:Get fulltext

Internet

Get fulltext

Similar Items